Stroke and bleeding risks in NOAC- and warfarin-treated patients with hypertrophic cardiomyopathy and atrial fibrillation - Noseworthy, P A; Yao, X; Shah, N D; Gersh, B J (J Am Coll Cardiol, 2016)